At the same time, empagliflozin was confirmed to increase AMPK activity and to inhibit Sonic Hedgehog Signalling Molecule (SHH) expression in these cells representing the main mechanisms of empagliflozin’s anticancer action against cervical cancer [133]. The gene discussed is SHH; the disease is cervical cancer.